Another young woman has suffered a blood clot while using Yaz/Yasmin.
She is alive. Thankfully.
And apparently once she put two and two together, she got pissed off enough that she’s now suing Bayer.
Kerry Sims was prescribed Yasmin for birth control. She alleges she suffered a blood clot in her lung and an infection surrounding the clot while on the pill. The complaint reportedly alleges that between 2004 and 2008 Yaz caused in excess of 50 deaths in women taking the pill, some as young as 17. Sims maintains that had she known the risks associated with Yaz/Yasmin she would not have taken it. Those “risks” refer to the likelihood of deep vein thrombosis (DVT); pulmonary embolism (PE); gallbladder complications and gallbladder disease; stroke; heart attack and death.
The evidence is mounting—evidence that shows the risk for developing potentially lethal blood clots such as deep vein thrombosis (DVT) in women taking new generation hormonal contraception is much higher than in women taking older generation oral contraceptives.
Two new studies published on the British Medical Journal’s website this month point to a higher incidence of DVT in women taking pills containing desogestrel (e.g., Cyclessa from Organon) and drospirenone (e.g., Yaz from Bayer Healthcare).
In one of the studies, conducted in the Netherlands, the researchers found a 6.3 fold increased risk for venous thrombosis (VT) associated with drospirenone—one of the hormones in Yaz/Yasmin—compared with rates for VT in non-users. That means the risk for VT increases 6 times above that seen in women not taking drospirenone.
Researchers involved in the second study, from Denmark, found a 1.64 increased risk for VT associated with drosperinone.
The researchers from the Netherlands concluded: Read the rest of this entry »
The media has been full of reports of lawsuits filed against Bayer recently, all related to the company’s oral contraceptives Yaz and Yasmin.
This week alone six lawsuits were filed in Toledo. The allegations in these suits focus on misrepresentation of the adverse effects associated with the pill. Those adverse effects would include stroke, embolism and other life-threatening events. According to the suits, Bayer did not advertise proper warnings and did not adequately disclose the potential risks. One of the suits was brought by the family of a 25-year old mother who died from a stroke in 2006, allegedly while taking Yaz.
Between the first quarter of 2004 and the third quarter of 2008 reports indicate that more than 50 Yasmin- or Yaz-related incidences of death were filed with the FDA, one involved a 17-year old woman. The causes of death allegedly involved pulmonary embolisms, stroke and cardiac arrests. Read the rest of this entry »
Watching the events unfold in Iran over the past week has proven a startling reminder of the power of shared information, especially as it applies to the Internet. The beauty of the Web is that people can share their experiences in their own voice, regardless of whether that experience is about an election gone terribly wrong, the death of a Pop legend such as Michael Jackson, or a woman’s own story about a terrible event in her life. That sharing of information not only helps keep people informed, but in some cases galvanizes them into action. Angela Beck is counting on both. Read the rest of this entry »